This week in Other Barks & Bites: The Trump Administration’s Final Rule that would have required list prices of drugs to be displayed in television ads is blocked by the U.S. District Court for the District of D.C.; the STRONGER Patents Act is reintroduced into both houses of Congress; the leadership of the Senate IP Subcommittee releases a statement on the splintered Federal Circuit en banc denial in Athena; the U.S. Copyright Office designates the mechanical licensing collective; Huawei is the top earner of Chinese patents thus far in 2019; Intel enters a period of exclusive talks in its wireless patent auction; T-Mobile and Sprint extend their merger deadline; Amazon launches initiative to retrain 100,000 employees for high-tech positions; and major drugmakers ask the Supreme Court to take up a patent case involving functional claiming issues.
- (Not) Copyright Infringement: Is dbrand Infringing Nintendo’s IP?
- The Transmissibility of Information: How Your Trade Secrets Are Like a Virus
- Examining Antitrust Guidance on Cooperation in Fighting COVID-19
- Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them
- Boys Will Be Boys: Getting a Foot in the Funding Door for Women Entrepreneurs
- This Week in Washington IP: Reconsidering the DMCA Takedown System, Bridging Gaps in Federal Data Privacy Legislation, and Developing Technologies for Inclusive Cities
- Caldwell IP Law Seeks Patent Attorney or Agent to Join its Boston Office
- Other Barks & Bites for Friday, May 29: USPTO Extends Filing Deadlines, PTAB Proposes New Rules Under SAS Institute and China IP Cases Up 5,660% in Two Decades
- Eleventh Circuit Finds ENGINEERED TAX SERVICES Mark Inherently Distinctive
- Section 512 Report Suggests Fine-Tuning Knowledge and Eligibility Requirements for DMCA Safe Harbors